Draft:Ambry Genetics

Konica Minolta Precision Medicine, Inc. Acquires Backpack Health Assets

Retrieved on: 
Wednesday, May 20, 2020
Data management, Health, Technology, Software, Pharmaceutical, Biotechnology, Companies, Konica Minolta, Economy of Japan, Industries, Minolta, Konica, Draft:Ambry Genetics, Konica Minolta Precision Medicine, Invicro, Ambry Genetics, Backpack Health

Konica Minolta Precision Medicine , Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform.

Key Points: 
  • Konica Minolta Precision Medicine , Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform.
  • We are incredibly excited for the team at Backpack Health to join the KMPM organization, stated Dr. Jack Hoppin, President of Konica Minolta Precision Medicine.
  • Konica Minolta Precision Medicine, Inc. (KMPM) based in Aliso Viejo, CA is a subsidiary of Konica Minolta, Inc. that includes Ambry Genetics Corporation and Invicro LLC.
  • Backpack Health, LLC builds secure, innovative information tools to help people manage their health journey including wellness, illnesses, injuries, and chronic health conditions.

Volpara Solutions Signs Collaboration Agreement with Ambry Genetics

Retrieved on: 
Wednesday, May 20, 2020
Medicine, Companies, Medical genetics, Konica Minolta, Medical tests, Branches of biology, Genetic testing, Volpara, Ambry, Draft:Ambry Genetics

WELLINGTON, New Zealand, May 20, 2020 /PRNewswire/ --Volpara Health Technologies announced today that its subsidiary company, Volpara Solutions , has signed a collaboration agreement with Ambry Genetics , one of the world's leading genetic testing companies.

Key Points: 
  • WELLINGTON, New Zealand, May 20, 2020 /PRNewswire/ --Volpara Health Technologies announced today that its subsidiary company, Volpara Solutions , has signed a collaboration agreement with Ambry Genetics , one of the world's leading genetic testing companies.
  • Ambry Genetics, part of Konica Minolta Precision Medicine, developed the CARE (Comprehensive, Assessment, Risk, and Education) Program.
  • Ambry and Volpara are collaborating to incorporate CARE with Volpara's cancer screening platform to automate the workflow by creating an online ordering process for genetic testing within the AspenBreast practice management software.
  • Our partnership with Ambry will allow us to offer additional value to our customers to ensure the right patients get the right testing at the right time," said Ralph Highnam, Ph.D., Volpara Solutions CEO.

Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine

Retrieved on: 
Monday, December 23, 2019
Software, Radiology, Biotechnology, Pharmaceutical, Oncology, Health, Technology, Other Health, Companies, Economy of Japan, Industries, Konica Minolta, Minolta, Konica, Draft:Ambry Genetics

Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer.

Key Points: 
  • Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer.
  • Dr. Jack Hoppin, co-founder of Invicro, will move on from his role as Invicros CEO to be the President of Konica Minolta Precision Medicine (KMPM).
  • As KMPM continues to focus on revolutionizing personalized healthcare via the strengths of Konica Minolta, Invicro and Ambry, Jack will be instrumental in leading and realizing the Konica Minolta Precision Medicine mission.
  • Konica Minolta Precision Medicine, Inc. (KMPM) based in Aliso Viejo, CA is a subsidiary of Konica Minolta, Inc. that includes Ambry Genetics Corporation and Invicro LLC.

Global Whole Genome And Exome Sequencing Market Report 2019: Forecast to 2023 & Executive and Consultant Guides 2020 to 2024

Retrieved on: 
Friday, November 1, 2019
Nanotechnology, Companies, Branches of biology, Biology, Konica Minolta, Nanopore sequencing, Molecular biology, Nanopore, Massachusetts Mutual Life Insurance Company, Minolta, Draft:Ambry Genetics

3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.

Key Points: 
  • 3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.
  • 3.3.4.1 What is Oxford Nanopore Sequencing?
  • 3.3.4.2 What can Oxford Nanopore Sequencingt be used for?
  • Human Longevity Launches Whole Genome Product, MassMutual Partnerships
    Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Whole Genome And Exome Sequencing Markets, 2023 - Research, Clinical, Direct to Consumer, AgriBio & Tumor - ResearchAndMarkets.com

Retrieved on: 
Friday, November 1, 2019
Health, Genetics, Nanotechnology, Companies, Branches of biology, Biology, Konica Minolta, Nanopore sequencing, Molecular biology, Nanopore, Massachusetts Mutual Life Insurance Company, Minolta, Draft:Ambry Genetics

3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.

Key Points: 
  • 3.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS.
  • 3.3.4.1 What is Oxford Nanopore Sequencing?
  • 3.3.4.2 What can Oxford Nanopore Sequencingt be used for?
  • Human Longevity Launches Whole Genome Product, MassMutual Partnerships
    Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Ambry Genetics' Data Reveal that Expanding Genetic Testing Guidelines Could Identify More Patients with Increased Risks of Cancer

Retrieved on: 
Tuesday, August 27, 2019
Medicine, Clinical medicine, Branches of biology, Alternatives to animal testing, Genetic testing, Medical genetics, Draft:Ambry Genetics

ALISO VIEJO, Calif., Aug. 27, 2019 /PRNewswire-PRWeb/ -- Ambry Genetics (Ambry), a leading clinical genetics testing company, announced today new opportunities to improve genetic testing guidelines.

Key Points: 
  • ALISO VIEJO, Calif., Aug. 27, 2019 /PRNewswire-PRWeb/ -- Ambry Genetics (Ambry), a leading clinical genetics testing company, announced today new opportunities to improve genetic testing guidelines.
  • In the largest cohort study of its kind, Ambry presents novel, detailed evidence on how to improve the guidelines to identify more at-risk patients.
  • Clinicians use guidelines to inform decisions about which patients should receive genetic testing for hereditary cancer and for those patients which genes should be tested.
  • These guidelines also have implications for how insurance plans cover genetic testing, and for appropriate medical management of patients after testing is complete.

Mergers and Acquisitions in the IVD Market, 2019 Report Featuring Major Players - Roche, Abbotts, Danaher, Siemens, Thermo Fisher Scientific

Retrieved on: 
Tuesday, August 6, 2019
Companies, Konica Minolta, CAC 40, Sanofi, Bioverativ, Konica, Ablynx, Minolta, Precision medicine, Draft:Ambry Genetics

Bruker Acquires Majority Interest in Hain Lifescience, Infectious Disease-focused MDx Company

Key Points: 
  • Bruker Acquires Majority Interest in Hain Lifescience, Infectious Disease-focused MDx Company
    Early 2018 M&A Activity in Biotech - Sanofi Buys Bioverativ, Ablynx
    Konica Minolta Acquires Ambry Genetics and Invicro, Building a Presence in Precision Medicine
    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.